Lifodrox (Moxifloxacin Hydrochloride)

Moxifloxacin hydrochloride blocks bacterial DNA gyrase and topoisomerase IV, enzymes that control DNA supercoiling and replication. By inhibiting these targets, the drug stops bacterial DNA synthesis and transcription, leading to rapid bacterial cell death. This bactericidal action covers a broad range of Gram‑positive and Gram‑negative ocular pathogens.

The exact dosing schedule for Lifodrox is determined by the prescribing clinician based on the severity of the infection, the specific organism involved, and patient factors. Typical regimens involve one or more drops per eye at defined intervals, but the prescriber sets the precise frequency and duration according to clinical guidelines.

Safety data for Lifodrox in pregnancy and lactation are limited. Because the potential risks are not well defined, the prescriber must weigh the benefits of treating a serious eye infection against any possible fetal or infant exposure. Consultation with an obstetrician or pediatrician is recommended before use in these populations.

To order Lifodrox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Both Lifodrox (moxifloxacin) and ciprofloxacin belong to the fluoroquinolone class and are effective against many ocular pathogens. Moxifloxacin generally offers a broader spectrum, including enhanced activity against Gram‑positive organisms and some resistant strains, and may require fewer daily administrations. Choice between them depends on local resistance patterns, physician preference and patient tolerance.

Lifodrox should be stored at room temperature, preferably below 25 °C, in its original container. Keep the bottle tightly closed, protect it from direct light and moisture, and avoid freezing. Do not refrigerate unless specifically instructed on the label, as temperature extremes can affect solution stability.

The patient should wash their hands, tilt the head back, and gently pull down the lower eyelid to create a small pocket. One drop is placed into the affected eye(s) as directed by the prescriber, avoiding contact between the tip of the bottle and the eye or surrounding tissues. The eye should be closed briefly to allow distribution, and contact lenses should be removed during treatment.

Serious adverse events, though rare, include allergic contact dermatitis of the eyelid or periocular skin, severe eye pain or photophobia, corneal ulceration or perforation, sudden loss of visual acuity, and systemic hypersensitivity reactions such as rash, fever, or anaphylaxis. Patients should seek immediate medical attention if any of these symptoms develop.

Lifodrox should not be used by individuals with a known hypersensitivity to moxifloxacin, other fluoroquinolones, or any excipients in the formulation. It is also contraindicated in patients with severe corneal epithelial defects, uncontrolled dry eye, or active ocular surface disease where the drug may exacerbate injury. Clinicians should assess each patient’s medical history before prescribing.